AnyGenes® is a R&D biotechnology, totally owned by its founders.
Based on more than 15 years of experience, AnyGenes has three main activities: i) produces, manufactures and markets innovative and focused panel assays of signaling pathways, epigenetic (methylation analysis), microbiome and biomarkers profiling for translational medicine, ii) services for drug development by using our proprietary molecular platform, iii) development of multi-biomarkers clinical tests